Company overview
USCC
91340100726322279A
Id2
340000000000889
English Name
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
Former names
安徽龙科马生物制药有限责任公司
Chinese Name
安徽智飞龙科马生物制药有限公司
Entity type
Limited Liability Company (Sole Legal-Person Ownership, Non-Natural Person)
Authorized capital
¥76,500
Phone
+8655165315667
Representative
李万军
Establishment date
5 January 2001
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 31 October 2022 | ID | 30024190 | Zifivax (Recombinant Protein Ncprbd Of Sars-Cov-2 Virus, Injection, Box 1 Vial @0.5Ml | PT Jakarta Biopharmaceutical Industry | ID | Anhui Zhifei Longcom Biopharmaceutical Company Limited | CN | $1,000,000.00 |
| 19 February 2021 | ID | 30049099 | Recombinant Novel Coronavirus Vaccine Placebo Baik & Baru | PT Bcht Bioteknologi Indonesia | ID | Anhui Zhifei Longcom Biopharma | CN | $36,068.40 |
| 19 February 2021 | ID | 30022090 | Recombinant Novel Coronavirus Vaccine (Cho Cell) Baik & Baru | PT Bcht Bioteknologi Indonesia | ID | Anhui Zhifei Longcom Biopharma | CN | $36,068.40 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Jakarta Biopharmaceutical Industry | buyer | $1,000,000 | 93.27% |
| PT Bcht Bioteknologi Indonesia | buyer | $72,137 | 6.73% |